Home > Healthcare & Medical Devices > Surgical Sealant and Adhesive Market
Surgical Sealant And Adhesive Market Size is expected to grow at a commendable pace from 2022 to 2028, on account of increasing rate of surgical interventions for late-stage chronic disease treatment. Surgical adhesives and sealants refer to naturally or synthetically-derived materials used as adjuncts to sutures in order to limit infections, restore compromised tissue boundaries and facilitate healing. These materials are emerging as potential replacements for staples and sutures in many medical applications, given their ability to minimize blood loss, improve closure and facilitate less painful and easier operation without the need for removal.
Growing prevalence of chronic health conditions like obesity and CVDs is a major factor stimulating surgical sealant and adhesive market trends till 2028. According to the CDC, nearly 659,000 people succumb to heart disease in the U.S. each year. This rise in chronic heart conditions has led to a heightened focus on surgical procedures for treatment, in turn driving demand for surgical adhesives and sealants. Fibrin glue, bioglue and GRF among other biological adhesives are commonly used in cardiac surgeries. In January 2020, Terumo Corporation introduced AQUABRID, its new surgical sealant solution developed specifically for aortic procedures, designed to achieve hemostasis even in the event of inhibited blood coagulation during cardiac surgery.
Cosmetic surgery is set to emerge as a major application segment for the surgical sealant and adhesive market by 2028, given the strong potential of the material in tissue engineering and regenerative therapies. In the aesthetics field, regenerative medicine is gaining rapid traction for various purposes, including reversal of tissue aging to repair of scarring. This will, in turn, boost demand for sealants and adhesives designed for use in treatment of traumatic injuries and burns.
APAC surgical sealant and adhesive market will gain significant momentum by 2028. This growth is attributed to the expanding geriatric population and subsequent increase in chronic disease burden in the region. Management of these chronic conditions requires various aspects of care, including surgical intervention, which could augment surgical adhesives and sealants demand over the coming years.
Integra LifeSciences, B. Braun Melsungen AG, Johnson & Johnson, C. R. Bard, Baxter International, Sanofi, CryoLife, Cohera Medical, Sealantis and Medtronic. These players are implementing several strategies like mergers & acquisitions, as well as portfolio expansions to maintain a strong presence in the global market space. In December 2021, for instance, Becton, Dickinson and Company announced the acquisition of Tissuemed, Ltd, an industry-leading developer of self-adhesive surgical sealant films. The objective behind the acquisition was to bring the Tissuepatch surgical sealant into BD’s biosurgery product suite and expand its offerings to surgeons outside the U.S.
The ramifications of the COVID-19 pandemic have been felt across the healthcare industry, particularly in the working of surgical procedures. With strict guidelines put into effect by regulatory authorities regarding non-emergent surgical cases, the volume of surgeries declined considerably in the initial months of the crisis, in turn influencing the adoption of sealants and adhesives for surgical use. However, recent months have witnessed a gradual turnaround, with non-emergent operations regaining traction, albeit in compliance with strict guidelines like PPE use, and limited patient and physician interaction. One of the major concerns for healthcare workers during the pandemic was the need of patients to remove superficial sutures post-surgery. Post-surgical and older patients are more susceptible to viral transmission, a factor that has urged many physicians to explore wound closure methods like surgical sealants and adhesives as alternatives to conventional sutures or staples, in order to mitigate the need for personal contact with patients.
Market, by Product
Market, by Application
Market, by End-use
The above information is provided for the following regions and countries: